Related Experiment Video
Updated: Feb 6, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Fasting hypoglycemia is associated with disease progression in presymptomatic early stage type 1 diabetes
Melanie Heinrich1, Nicole Maison1, Peter Achenbach1
1Institute of Diabetes Research, Helmholtz Zentrum München, Munich, Germany, and Forschergruppe Diabetes der Technischen Universität München, Munich, Germany.
Insights
Fasting hypoglycemia in children with presymptomatic type 1 diabetes may signal disease progression. This finding suggests hypoglycemia could be a new marker for identifying children needing closer monitoring for type 1 diabetes development.
Area of Science:
- Pediatrics
- Endocrinology
- Immunology
Background:
- Presymptomatic type 1 diabetes in children is characterized by hyperglycemia and rising HbA1c.
- Hypoglycemia has been anecdotally reported in presymptomatic type 1 diabetes.
Purpose of the Study:
- To investigate the prevalence of hypoglycemia in children with presymptomatic type 1 diabetes.
- To determine if hypoglycemia is associated with disease progression.
Main Methods:
- Compared fasting glucose levels in autoantibody-negative and autoantibody-positive children (ages 2-5).
- Categorized autoantibody-positive children into hypoglycemic, normoglycemic, or hyperglycemic fasting groups.
- Assessed glucose response during oral glucose tolerance tests (OGTTs).
Main Results:
- 5.1% of autoantibody-positive children had fasting hypoglycemia; none in autoantibody-negative group.
- Fasting hypoglycemia was more frequent in later stages (2-3) of type 1 diabetes progression (P=0.02).
- Hypoglycemic children showed higher 120-minute OGTT glucose levels and more pathological OGTTs (P=0.04).
Conclusions:
- Fasting hypoglycemia may indicate disease progression in presymptomatic type 1 diabetes.
- Hypoglycemia could serve as a novel marker for closer monitoring of disease progression.
- Identifies children at higher risk for developing insulin-dependent type 1 diabetes.
Objective:
In children with presymptomatic type 1 diabetes, intermittent hyperglycemia and rising hemoglobin A1c levels are a known signal of progression toward insulin-dependency. Episodes of hypoglycemia, however, have also been reported in one published case. We investigated the prevalence of hypoglycemia and its association with disease progression in children with presymptomatic type 1 diabetes.
Methods:
We compared the frequency of hypoglycemic fasting blood glucose levels (<60 mg/dL) in 48 autoantibody negative and 167 multiple β-cell autoantibody positive children aged 2 to 5 years. We classified the autoantibody positive children into three categories based on their glucose levels in fasting state (hypoglycemic [<60 mg/dL], normoglycemic [60-99 mg/dL] or hyperglycemic [≥100 mg/dL]). We then compared the glucose levels under challenge during oral glucose tolerance tests (OGTTs) between the three categories.
Results:
In the autoantibody positive children, 5.1% of the fasting samples were hypoglycemic, while in the autoantibody negative children no hypoglycemia was observed. Hypoglycemia occurred more often in autoantibody positive children who had already entered stage 2 or stage 3 of type 1 diabetes than in stage 1 patients (P = 0.02). Children who had hypoglycemic compared to normoglycemic fasting blood glucose values had higher 120-minute blood glucose values under OGTT challenge, and a higher rate of pathological OGTTs (P = 0.04).
Conclusions:
Fasting hypoglycemia seems to be an indicator of disease progression in presymptomatic type 1 diabetes and may therefore represent a novel marker for the identification of children who should be monitored more closely for progression toward insulin-dependent type 1 diabetes.
Related Concept Videos
Hypoglycemia and Glucagon
Piaget's Stage 1 of Cognitive Development
Exploration...
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

